Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1985 Oct;62:105–108. doi: 10.1289/ehp.8562105

Detection of 8,9-dihydro-(7'-guanyl)-9-hydroxyaflatoxin B1 in human urine.

H Autrup, J Wakhisi, K Vahakangas, A Wasunna, C C Harris
PMCID: PMC1568656  PMID: 3936705

Abstract

A possible role of aflatoxin B1 (AFB) in the etiology of human liver cancer has been suggested from several epidemiological studies. This has been based upon the association between consumption of AFB-contaminated food and the liver cancer incidence in different parts of the world. To further establish the role of AFB as a major factor, we initiated a pilot study in three different districts of Kenya to determine the number of individuals exposed to significant amounts of AFB as measured by the urinary excretion of 8,9-dihydro-8-(7-guanyl)-9-hydroxyaflatoxin B1 (AFB-Gua), an adduct formed between the ultimate carcinogenic form of AFB and nucleic acids. This product has previously been detected in urine from rats treated with AFB. Urine collected at the outpatient clinics at the district hospitals were concentrated on C18 Sep-Pak columns and analyzed by high-pressure liquid chromatography under two different chromatographic conditions. The chemical identity of the samples showing a positive response in both chromatographic systems was verified by synchronous scanning fluorescence spectrophotometry. The highest number of individuals with detectable urinary AFB-Gua lived in either Murang'a district or the neighboring Meru and Embu districts. In Murang'a district a rate of 12% was observed in the January-March period, while only 1 of 32 patients (3%) had a detectable exposure in July-August.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Autrup H., Harris C. C., Wu S. M., Bao L. Y., Pei X. F., Lu S., Sun T. T., Hsia C. C. Activation of chemical carcinogens by cultured human fetal liver, esophagus and stomach. Chem Biol Interact. 1984 Jun;50(1):15–25. doi: 10.1016/0009-2797(84)90128-5. [DOI] [PubMed] [Google Scholar]
  2. Bennett R. A., Essigmann J. M., Wogan G. N. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats. Cancer Res. 1981 Feb;41(2):650–654. [PubMed] [Google Scholar]
  3. Campbell T. C., Caedo J. P., Jr, Bulatao-Jayme J., Salamat L., Engel R. W. Aflatoxin M1 in human urine. Nature. 1970 Jul 25;227(5256):403–404. doi: 10.1038/227403a0. [DOI] [PubMed] [Google Scholar]
  4. Chetsanga C. J., Frenette G. P. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase. Carcinogenesis. 1983 Aug;4(8):997–1000. doi: 10.1093/carcin/4.8.997. [DOI] [PubMed] [Google Scholar]
  5. Croy R. G., Essigmann J. M., Reinhold V. N., Wogan G. N. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1745–1749. doi: 10.1073/pnas.75.4.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Croy R. G., Wogan G. N. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res. 1981 Jan;41(1):197–203. [PubMed] [Google Scholar]
  7. Essigmann J. M., Croy R. G., Nadzan A. M., Busby W. F., Jr, Reinhold V. N., Büchi G., Wogan G. N. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci U S A. 1977 May;74(5):1870–1874. doi: 10.1073/pnas.74.5.1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Foster P. L., Eisenstadt E., Miller J. H. Base substitution mutations induced by metabolically activated aflatoxin B1. Proc Natl Acad Sci U S A. 1983 May;80(9):2695–2698. doi: 10.1073/pnas.80.9.2695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Haugen A., Groopman J. D., Hsu I. C., Goodrich G. R., Wogan G. N., Harris C. C. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4124–4127. doi: 10.1073/pnas.78.7.4124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hemminki K. Dimethylnitrosamine adducts excreted in rat urine. Chem Biol Interact. 1982 Mar 15;39(2):139–148. doi: 10.1016/0009-2797(82)90117-x. [DOI] [PubMed] [Google Scholar]
  11. Hertzog P. J., Lindsay Smith J. R., Garner R. C. A high pressure liquid chromatography study on the removal of DNA-bound aflatoxin B1 in rat liver and in vitro. Carcinogenesis. 1980 Sep;1(9):787–793. doi: 10.1093/carcin/1.9.787. [DOI] [PubMed] [Google Scholar]
  12. Hertzog P. J., Smith J. R., Garner R. C. Characterisation of the imidazole ring-opened forms of trans-8,9-dihydro-8,9-dihydro-8-(7-guanyl)9-hydroxy aflatoxin B1. Carcinogenesis. 1982;3(6):723–725. doi: 10.1093/carcin/3.6.723. [DOI] [PubMed] [Google Scholar]
  13. Lin J. K., Miller J. A., Miller E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 1977 Dec;37(12):4430–4438. [PubMed] [Google Scholar]
  14. Peers F. G., Gilman G. A., Linsell C. A. Dietary aflatoxins and human liver cancer. A study in Swaziland. Int J Cancer. 1976 Feb 15;17(2):167–176. doi: 10.1002/ijc.2910170204. [DOI] [PubMed] [Google Scholar]
  15. Peers F. G., Linsell C. A. Dietary aflatoxins and liver cancer--a population based study in Kenya. Br J Cancer. 1973 Jun;27(6):473–484. doi: 10.1038/bjc.1973.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Perera F. P., Poirier M. C., Yuspa S. H., Nakayama J., Jaretzki A., Curnen M. M., Knowles D. M., Weinstein I. B. A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. Carcinogenesis. 1982;3(12):1405–1410. doi: 10.1093/carcin/3.12.1405. [DOI] [PubMed] [Google Scholar]
  17. Pestka J. J., Li Y. K., Chu F. S. Reactivity of aflatoxin B2a antibody with aflatoxin B1-modified DNA and related metabolites. Appl Environ Microbiol. 1982 Nov;44(5):1159–1165. doi: 10.1128/aem.44.5.1159-1165.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shamsuddin A. K., Sinopoli N. T., Hemminki K., Boesch R. R., Harris C. C. Detection of benzo(a)pyrene:DNA adducts in human white blood cells. Cancer Res. 1985 Jan;45(1):66–68. [PubMed] [Google Scholar]
  19. Tsuboi S., Nakagawa T., Tomita M., Seo T., Ono H., Kawamura K., Iwamura N. Detection of aflatoxin B1 in serum samples of male Japanese subjects by radioimmunoassay and high-performance liquid chromatography. Cancer Res. 1984 Mar;44(3):1231–1234. [PubMed] [Google Scholar]
  20. Wang T. C., Cerutti P. A. Effect of formation and removal of aflatoxin B1:DNA adducts in 10T 1/2 mouse embryo fibroblasts on cell viability. Cancer Res. 1980 Aug;40(8 Pt 1):2904–2909. [PubMed] [Google Scholar]
  21. Wu S. M. [Urinary excretion of aflatoxin M1 (AFM1) in Beijing and Qidong inhabitants]. Zhonghua Zhong Liu Za Zhi. 1984 May;6(3):163–167. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES